Luxury Hard Shell Hyperbaric Chamber 2.0 ATA Vertical Hyperbaric Oxygenation Chamber for Humans Hbot Therapy

Name: Luxury Hard Shell Hyperbaric Chamber 2.0 ATA Vertical Hyperbaric Oxygenation Chamber for Humans Hbot Therapy
Brand: Nanjing Kaohammer Intelligent Technology Co., Ltd.
SKU: 2000337411

Jiangsu, ChinaNanjing Kaohammer Intelligent Technology Co., Ltd.

US$19,399.00

1 Piece

Product specifications

Pressure

Product profile

Customization

Available

Type

Hard-Shell Chamber / Rigid Chamber

Function

Hyperbaric Oxygen Therapy (Hbot)

Model NO.

HC-S10

Theory

Dissolved Oxygen in Plasma

Certification

CE, ISO13485, Mdr/Ukca/FCC/LVD/EMC

LCD Display

With LCD Display

Group

Adult

Pressure Options

2.0ATA Hyperbaric Oxygen Therapy (Hbot)

Oxygen Purity

≥93%±3 (Standard Medical Grade)

Oxygen Concentrator

15L/Min

Chamber Type

Hard Shell Hyperbaric Oxygen Cabin

Transport Package

Carton + Wooden Case

Specification

1.1-2.0ATA / Customized

Trademark

Kaohammer

Origin

China

Production Capacity

500set / Month

Company profile

High Repeat Buyers ChoiceFast DeliveryFull CustomizationManagement Certification

Nanjing Kaohammer Intelligent Technology Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2016-06-21Nearest Port: Ningbo, Shenzhen, HongkongAverage Response Time: ≤2.05hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, FCA, Others, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT

AI-Powered supplier vetting

SummaryKaoHammer Intelligent Technology Co., Ltd. is identified as a China-based trading company established in 2019, while the supplier describes a hyperbaric oxygen chamber R&D and production base in Nanjing. Evidence indicates ISO9001:2015 certification, claimed compliance with CE and ISO13485-related medical equipment standards, patents, and exports to more than 130 countries. The supplier offers medical, civilian, and home-use hyperbaric oxygen products, supports OEM/ODM customization, and describes installation, customs-clearance, and after-sales maintenance services. However, several operational fields remain unknown, and the records show only one year of R&D engineer experience, 2 production lines, 11–20 quality-control staff, and 2 total employees, creating unresolved questions about organizational and manufacturing scale. No financial figures are assessed.

CertificationsThe supplier holds an ISO9001:2015 certificate and claims product compliance with international medical-equipment standards including CE and ISO13485, along with multinational safety certifications. A TUV Rheinland audit is recorded, but the audit result is listed as 0 and the specific certification scope and audit interpretation are not provided.

After-Sales capabilityThe supplier describes one-stop support covering customs clearance, on-site installation, and after-sales maintenance. However, its in-stock service capacity, overseas warehouse capability, and overseas showroom capability are all marked unknown, so the breadth and delivery infrastructure of after-sales support cannot be fully verified.

R&D capabilityThe supplier claims independent R&D, multiple hyperbaric oxygen technology patents, an advanced R&D center, and intelligent functions such as real-time monitoring and remote management. Specific new-product R&D, ODM, and SDK capabilities are marked unknown, while the recorded total R&D engineer experience is 1 year.

Production capacityThe supplier states that it has a complete production base and records 2 production lines and 11–20 quality-control staff. Nevertheless, outsourcing procedures, manufacturing-capacity contracts, inventory capability, and the relationship between the stated production base and its Trading Company classification are unknown.

Customization capabilityThe supplier explicitly supports OEM/ODM cooperation and customization of cabin size, interior, pressure parameters, and brand logo, and reports customized solutions for customers in Europe, America, the Middle East, and Southeast Asia. Broader ODM process and R&D-service details remain unknown.